1. Home
  2. ALXO vs POWW Comparison

ALXO vs POWW Comparison

Compare ALXO & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.67

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$2.01

Market Cap

242.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALXO
POWW
Founded
2015
1990
Country
United States
United States
Employees
N/A
81
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
240.8M
242.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ALXO
POWW
Price
$1.67
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$3.50
$2.40
AVG Volume (30 Days)
941.0K
397.6K
Earning Date
05-08-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
26.36
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.56
Revenue Next Year
N/A
$0.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.08
52 Week High
$2.66
$2.23

Technical Indicators

Market Signals
Indicator
ALXO
POWW
Relative Strength Index (RSI) 35.80 47.43
Support Level $1.54 $1.96
Resistance Level $2.24 $2.11
Average True Range (ATR) 0.11 0.06
MACD -0.04 0.01
Stochastic Oscillator 2.38 52.50

Price Performance

Historical Comparison
ALXO
POWW

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

Share on Social Networks: